Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28

Immune checkpoint inhibitors have revolutionized cancer therapy leading to exceptional success. However, there is still the need to improve their efficacy in non‐responder patients. Natural killer (NK) cells represent the first line of defence against tumours, due to their ability to release immunom...

Descripción completa

Detalles Bibliográficos
Autores principales: Mariotti, F.R., Quatrini, L., Munari, E., Vacca, P., Tumino, N., Pietra, G., Mingari, M.C., Moretta, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
IUPHAR Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279970/
https://www.ncbi.nlm.nih.gov/pubmed/32335915
http://dx.doi.org/10.1111/bph.15081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279970/
https://www.ncbi.nlm.nih.gov/pubmed/32335915
http://dx.doi.org/10.1111/bph.15081

Ejemplares similares